198 related articles for article (PubMed ID: 19289695)
21. A new severe mutation in the SLC5A7 gene related to congenital myasthenic syndrome type 20.
Pardal-Fernández JM; Carrascosa-Romero MC; Álvarez S; Medina-Monzón MC; Caamaño MB; de Cabo C
Neuromuscul Disord; 2018 Oct; 28(10):881-884. PubMed ID: 30172469
[TBL] [Abstract][Full Text] [Related]
22. Synaptic congenital myasthenic syndrome in three patients due to a novel missense mutation (T441A) of the COLQ gene.
Müller JS; Petrova S; Kiefer R; Stucka R; König C; Baumeister SK; Huebner A; Lochmüller H; Abicht A
Neuropediatrics; 2004 Jun; 35(3):183-9. PubMed ID: 15248101
[TBL] [Abstract][Full Text] [Related]
23. Congenital myasthenic syndromes.
Sieb JP; Kraner S; Steinlein OK
Semin Pediatr Neurol; 2002 Jun; 9(2):108-19. PubMed ID: 12138995
[TBL] [Abstract][Full Text] [Related]
24. [Congenital insensitivity to pain with anhidrosis associated with congenital myasthenic syndrome].
Raspall-Chaure M; Del Toro-Riera M; Gratacós M; Cuenca-León E; Ferrer I; Indo Y; Roig-Quilis M; Macaya-Ruiz A
Rev Neurol; 2005 Aug 16-31; 41(4):218-22. PubMed ID: 16075400
[TBL] [Abstract][Full Text] [Related]
25. Congenital myasthenic syndrome: a brief review.
Lorenzoni PJ; Scola RH; Kay CS; Werneck LC
Pediatr Neurol; 2012 Mar; 46(3):141-8. PubMed ID: 22353287
[TBL] [Abstract][Full Text] [Related]
26. [Molecular bases and therapeutic strategies in defective neuromuscular transmissions: lessons learned from a prototypical synapse].
Ohno K; Ito M; Masuda A
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Aug; 29(4):145-51. PubMed ID: 19764481
[TBL] [Abstract][Full Text] [Related]
27. Identification of a mutation in the CHAT gene of Old Danish Pointing Dogs affected with congenital myasthenic syndrome.
Proschowsky HF; Flagstad A; Cirera S; Joergensen CB; Fredholm M
J Hered; 2007; 98(5):539-43. PubMed ID: 17586598
[TBL] [Abstract][Full Text] [Related]
28. Congenital myasthenic syndromes: A diverse array of molecular targets.
Engel AG; Ohno K; Sine SM
J Neurocytol; 2003; 32(5-8):1017-37. PubMed ID: 15034283
[TBL] [Abstract][Full Text] [Related]
29. A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions.
Chevessier F; Girard E; Molgó J; Bartling S; Koenig J; Hantaï D; Witzemann V
Hum Mol Genet; 2008 Nov; 17(22):3577-95. PubMed ID: 18718936
[TBL] [Abstract][Full Text] [Related]
30. Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission.
Müller JS; Mihaylova V; Abicht A; Lochmüller H
Expert Rev Mol Med; 2007 Aug; 9(22):1-20. PubMed ID: 17686188
[TBL] [Abstract][Full Text] [Related]
31. Sleuthing molecular targets for neurological diseases at the neuromuscular junction.
Engel AG; Ohno K; Sine SM
Nat Rev Neurosci; 2003 May; 4(5):339-52. PubMed ID: 12728262
[No Abstract] [Full Text] [Related]
32. Congenital myasthenic syndrome: report of four cases and brief review of literature.
Khwaja GA; Chowdhury D; Gupta M
Neurol India; 2000 Sep; 48(3):266-71. PubMed ID: 11025633
[TBL] [Abstract][Full Text] [Related]
33. Congenital endplate acetylcholinesterase deficiency responsive to ephedrine.
Bestue-Cardiel M; Sáenz de Cabezón-Alvarez A; Capablo-Liesa JL; López-Pisón J; Peña-Segura JL; Martin-Martinez J; Engel AG
Neurology; 2005 Jul; 65(1):144-6. PubMed ID: 16009904
[TBL] [Abstract][Full Text] [Related]
34. Congenital myasthenic syndrome: a rare, potentially treatable cause of respiratory failure in a "floppy" infant.
McConkey PP; Mullens AJ
Anaesth Intensive Care; 2000 Feb; 28(1):82-6. PubMed ID: 10701044
[TBL] [Abstract][Full Text] [Related]
35. Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations.
Schara U; Barisic N; Deschauer M; Lindberg C; Straub V; Strigl-Pill N; Wendt M; Abicht A; Müller JS; Lochmüller H
Neuromuscul Disord; 2009 Dec; 19(12):828-32. PubMed ID: 19837590
[TBL] [Abstract][Full Text] [Related]
36. Congenital myasthenic syndrome type 19 due to a novel mutation in the COL13A1 GENE.
Marquardt RJ; Li Y
Muscle Nerve; 2019 Jul; 60(1):E3-E4. PubMed ID: 31018245
[No Abstract] [Full Text] [Related]
37. Quinine sulfate as a therapeutic option in a patient with slow channel congenital myasthenic syndrome.
Peyer AK; Abicht A; Heinimann K; Sinnreich M; Fischer D
Neuromuscul Disord; 2013 Jul; 23(7):571-4. PubMed ID: 23688972
[TBL] [Abstract][Full Text] [Related]
38. Congenital myasthenic syndrome due to rapsyn deficiency: A case report with a new mutation and compound heterozygosity.
Espinoza IO; Reynoso C; Chávez G; Engel AG
Medwave; 2019 Jun; 19(5):e7645. PubMed ID: 31226102
[TBL] [Abstract][Full Text] [Related]
39. Presynaptic congenital myasthenic syndrome due to three novel mutations in SLC5A7 encoding the sodium-dependant high-affinity choline transporter.
Rodríguez Cruz PM; Hughes I; Manzur A; Munot P; Ramdas S; Wright R; Breen C; Pitt M; Pagnamenta AT; Taylor JC; Palace J; Beeson D
Neuromuscul Disord; 2021 Jan; 31(1):21-28. PubMed ID: 33250374
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations.
Wargon I; Richard P; Kuntzer T; Sternberg D; Nafissi S; Gaudon K; Lebail A; Bauche S; Hantaï D; Fournier E; Eymard B; Stojkovic T
Neuromuscul Disord; 2012 Apr; 22(4):318-24. PubMed ID: 22088788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
